GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.

Have any questions? Please email us at ecoliwiki@gmail.com

PMID:21866101

From GONUTS
Jump to: navigation, search
Citation

Côté, M, Misasi, J, Ren, T, Bruchez, A, Lee, K, Filone, CM, Hensley, L, Li, Q, Ory, D, Chandran, K and Cunningham, J (2011) Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 477:344-8

Abstract

Ebola virus (EboV) is a highly pathogenic enveloped virus that causes outbreaks of zoonotic infection in Africa. The clinical symptoms are manifestations of the massive production of pro-inflammatory cytokines in response to infection and in many outbreaks, mortality exceeds 75%. The unpredictable onset, ease of transmission, rapid progression of disease, high mortality and lack of effective vaccine or therapy have created a high level of public concern about EboV. Here we report the identification of a novel benzylpiperazine adamantane diamide-derived compound that inhibits EboV infection. Using mutant cell lines and informative derivatives of the lead compound, we show that the target of the inhibitor is the endosomal membrane protein Niemann-Pick C1 (NPC1). We find that NPC1 is essential for infection, that it binds to the virus glycoprotein (GP), and that antiviral compounds interfere with GP binding to NPC1. Combined with the results of previous studies of GP structure and function, our findings support a model of EboV infection in which cleavage of the GP1 subunit by endosomal cathepsin proteases removes heavily glycosylated domains to expose the amino-terminal domain, which is a ligand for NPC1 and regulates membrane fusion by the GP2 subunit. Thus, NPC1 is essential for EboV entry and a target for antiviral therapy.

Links

PubMed PMC3230319 Online version:10.1038/nature10380

Keywords

Adamantane/analogs & derivatives; Adamantane/chemistry; Animals; Antiviral Agents/chemistry; Antiviral Agents/pharmacology; Carrier Proteins/metabolism; Cathepsins/metabolism; Cell Line; Cercopithecus aethiops; Ebolavirus/drug effects; Ebolavirus/physiology; Endosomes/enzymology; Glycoproteins/metabolism; Hemorrhagic Fever, Ebola/drug therapy; Hemorrhagic Fever, Ebola/metabolism; Humans; Membrane Fusion/drug effects; Membrane Glycoproteins/metabolism; Molecular Weight; Piperazines/chemistry; Vero Cells; Viral Fusion Proteins/metabolism; Virus Internalization/drug effects

Significance

Annotations

Gene product Qualifier GO Term Evidence Code with/from Aspect Extension Notes Status

HUMAN:NPC1

GO:0046718: entry of virus into host cell

ECO:0000315:

P

Fig. 2B (infection) and 2C/2D (virus entry into cell)

complete
CACAO 2104

HUMAN:NPC1

involved_in

GO:0046718: viral entry into host cell

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete

MOUSE:NPC1

GO:0046718: entry of virus into host cell

ECO:0000315:

P

Fig. 2C and Fig. 2D

complete
CACAO 2106

MOUSE:NPC1

involved_in

GO:0046718: viral entry into host cell

ECO:0000315: mutant phenotype evidence used in manual assertion

P

Seeded From UniProt

complete


See also

References

See Help:References for how to manage references in GONUTS.